Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.22 -0.01 (-0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Iovance Biotherapeutics (IOVA) Long-Term Investments (2021 - 2022)

Updated

Iovance Biotherapeutics (IOVA) reported Long-Term Investments of $27.7 million for Q1 2022, up 170.9% from $10.23 million a year earlier but down 69.8% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Long-Term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, Iovance Biotherapeutics posted Long-Term Investments of $91.59 million.

  • Five-year quarterly Long-Term Investments spans a low of $10.23 million in Q1 2021 and a high of $91.59 million in Q4 2021.
  • Per Business Quant data, the three quarters before Q1 2022 came in at $91.59 million (Q4 2021), $78.25 million (Q3 2021) and $46.3 million (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 Iovance Biotherapeutics 6.45 Bn 5.24 Bn 55.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 27.70 Mn
Dec 31, 2021 91.59 Mn
Sep 30, 2021 78.25 Mn
Jun 30, 2021 46.30 Mn
Mar 31, 2021 10.23 Mn
API Access

Iovance Biotherapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=IOVA&period=max&api_key=YOUR_API_KEY